054050 — Nong Woo Bio Co Income Statement
0.000.00%
- KR₩125bn
- KR₩128bn
- KR₩136bn
- 81
- 71
- 19
- 61
Annual income statement for Nong Woo Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 121,267 | 130,030 | 132,843 | 133,400 | 135,844 |
Cost of Revenue | |||||
Gross Profit | 58,565 | 59,741 | 63,203 | 65,593 | 66,181 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 117,334 | 125,997 | 127,163 | 123,510 | 127,673 |
Operating Profit | 3,933 | 4,033 | 5,680 | 9,890 | 8,171 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5,912 | 7,770 | 7,581 | 10,812 | 9,980 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6,986 | 9,456 | 6,953 | 9,886 | 10,169 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 6,984 | 9,400 | 6,930 | 9,879 | 10,333 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 6,984 | 9,400 | 6,930 | 9,879 | 10,333 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 423 | 584 | 494 | 661 | 625 |
Dividends per Share |